The emergence of Parkinson disease among patients with Gaucher disease

作者: Deborah Elstein , Roy Alcalay , Ari Zimran

DOI: 10.1016/J.BEEM.2014.08.007

关键词:

摘要: In the last decade, several lines of evidence have been presented that document clinical manifestations, genetic associations, and sub-cellular mechanisms inter-relatedness β-glucocerebrosidase mutations emergence Parkinson disease among carriers patients with Gaucher disease. This review is an attempt to apprise reader recent literature caveat this area intensive exploration constantly being updated because immediate ramifications but also impact on our understanding disease, finally unexpected inter-reactions between these entities molecular level. It has happenstance it discovered a rare monogenetic interface at many points neurological disorder elderly both familial sporadic forms: date there no cure for either disorders.

参考文章(79)
Ellen Sidransky, Gaucher disease: insights from a rare Mendelian disorder. Discovery Medicine. ,vol. 14, pp. 273- 281 ,(2012)
Raquel Duran, Niccolo E. Mencacci, Aikaterini V. Angeli, Maryam Shoai, Emma Deas, Henry Houlden, Atul Mehta, Derralynn Hughes, Timothy M. Cox, Patrick Deegan, Anthony H. Schapira, Andrew J. Lees, Patricia Limousin, Paul R. Jarman, Kailash P. Bhatia, Nicholas W. Wood, John Hardy, Tom Foltynie, The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease Movement Disorders. ,vol. 28, pp. 232- 236 ,(2013) , 10.1002/MDS.25248
Aikaterina Angeli, Niccolo E. Mencacci, Raquel Duran, Iciar Aviles-Olmos, Zinovia Kefalopoulou, Joseph Candelario, Sarah Rusbridge, Jennifer Foley, Priyanka Pradhan, Marjan Jahanshahi, Ludvic Zrinzo, Marwan Hariz, Nicholas W. Wood, John Hardy, Patricia Limousin, Tom Foltynie, Genotype and phenotype in Parkinson's disease: Lessons in heterogeneity from deep brain stimulation Movement Disorders. ,vol. 28, pp. 1370- 1375 ,(2013) , 10.1002/MDS.25535
Ozlem Goker-Alpan, Barbara K. Stubblefield, Benoit I. Giasson, Ellen Sidransky, Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders Acta Neuropathologica. ,vol. 120, pp. 641- 649 ,(2010) , 10.1007/S00401-010-0741-7
Satoshi Kono, Kentaro Shirakawa, Yasuomi Ouchi, Masanobu Sakamoto, Hiroyuki Ida, Takeshi Sugiura, Hiroyuki Tomiyama, Hitoshi Suzuki, Yoshitomo Takahashi, Hiroaki Miyajima, Nobutaka Hattori, Yoshikuni Mizuno, Dopaminergic neuronal dysfunction associated with parkinsonism in both a Gaucher disease patient and a carrier. Journal of the Neurological Sciences. ,vol. 252, pp. 181- 184 ,(2007) , 10.1016/J.JNS.2006.10.019
B. Bembi, S. Zambito Marsala, E. Sidransky, G. Ciana, M. Carrozzi, M. Zorzon, C. Martini, M. Gioulis, M.G. Pittis, L. Capus, Gaucher’s disease with Parkinson’s disease Clinical and pathological aspects Neurology. ,vol. 61, pp. 99- 101 ,(2003) , 10.1212/01.WNL.0000072482.70963.D7
Leonard Petrucelli, Casey O'Farrell, Paul J. Lockhart, Melisa Baptista, Kathryn Kehoe, Liselot Vink, Peter Choi, Benjamin Wolozin, Matthew Farrer, John Hardy, Mark R. Cookson, Parkin Protects against the Toxicity Associated with Mutant α-Synuclein: Proteasome Dysfunction Selectively Affects Catecholaminergic Neurons Neuron. ,vol. 36, pp. 1007- 1019 ,(2002) , 10.1016/S0896-6273(02)01125-X
Y.-R. Wu, C.-M. Chen, C.-Y. Chao, L.-S. Ro, R.-K. Lyu, K.-H. Chang, G.-J. Lee-Chen, Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese. Journal of Neurology, Neurosurgery, and Psychiatry. ,vol. 78, pp. 977- 979 ,(2007) , 10.1136/JNNP.2006.105940
N Tayebi, J Walker, B Stubblefield, E Orvisky, ME LaMarca, K Wong, H Rosenbaum, R Schiffmann, B Bembi, E Sidransky, Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Molecular Genetics and Metabolism. ,vol. 79, pp. 104- 109 ,(2003) , 10.1016/S1096-7192(03)00071-4